Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

We have investigated the use of the antibody MIB1 as a proliferative and prognostic marker in breast cancer and whether changes in proliferative activity could account for differences in prognosis of premenopausal women operated on during different phases of the menstrual cycle. MIB1 expression was...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cooper, L. S., Gillett, C. E., Smith, P., Fentiman, I. S., Barnes, D. M.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1998
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2150202/
https://ncbi.nlm.nih.gov/pubmed/9652769
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki